Literature DB >> 4269560

Generation of cytotoxic lymphocytes in mixed lymphocyte reactions. I. Specificity of the effector cells.

J Forman, G Möller.   

Abstract

Generation of cytotoxic effector cells by a unidirectional mixed lymphocyte reaction (MLR) in the mouse H-2 system was studied using labeled YAC (H-2(a)) leukemia cells as targets. The responding effector cell displayed a specific cytotoxic effect against target cells of the same H-2 genotype as the stimulating cell population. Killing of syngeneic H-2 cells was not observed, even when the labeled target cells were "innocent bystanders" in cultures where specific target cells were reintroduced. Similar results were found with spleen cells taken from mice sensitized in vivo 7 days earlier. The effector cell was not an adherent cell and was not activated by supernatants from MLR. The supernatants were not cytotoxic by themselves. When concanavalin A or phytohemagglutinin was added to the cytotoxic test system, target and effector cells were agglutinated. Under these conditions, killing of H-2(a) target cells was observed in mixed cultures where H-2(a) lymphocytes were also the effector cells. These findings indicate that specifically activated, probably thymus-derived lymphocytes, can kill nonspecifically once they have been activated and providing there is close contact between effector and target cells. Thus, specificity of T cell killing appears to be restricted to recognition and subsequent binding to the targets, the actual effector phase being nonspecific.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4269560      PMCID: PMC2139411          DOI: 10.1084/jem.138.3.672

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  23 in total

1.  Tumor-graft rejection in syngeneic guinea pigs: evidence for a two-step mechanism.

Authors:  B Zbar; H T Wepsic; T Borsos; H J Rapp
Journal:  J Natl Cancer Inst       Date:  1970-02       Impact factor: 13.506

2.  Evidence for a receptor recognizing antigen complexed immunoglobulin on the surface of activated mouse thymus lymphocytes.

Authors:  T O Yoshida; B Andersson
Journal:  Scand J Immunol       Date:  1972       Impact factor: 3.487

3.  Mitogen-induced lymphocyte-mediated cytotoxicity in vitro: effect of mitogens selectively activating T or B cells.

Authors:  G Möller; O Sjöberg; J Andersson
Journal:  Eur J Immunol       Date:  1972-12       Impact factor: 5.532

4.  Mechanism of immunologically specific killing of tumour cells by macrophages.

Authors:  R Evans; P Alexander
Journal:  Nature       Date:  1972-03-24       Impact factor: 49.962

Review 5.  T-cell mediated immunity in vitro: an analysis of antigen recognition and target cell lysis.

Authors:  M Feldman; I R Cohen; H Wekerle
Journal:  Transplant Rev       Date:  1972

6.  When allogeneic mouse spleen cells are mixed in vitro the T-cells secrete a product which guides the maturation of B-cells.

Authors:  S Britton
Journal:  Scand J Immunol       Date:  1972       Impact factor: 3.487

7.  Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and incompatible tumor cells.

Authors:  E Klein; G Klein
Journal:  Cell Immunol       Date:  1972-09       Impact factor: 4.868

8.  Immunization of normal mouse spleen cell suspensions in vitro.

Authors:  R I Mishell; R W Dutton
Journal:  Science       Date:  1966-08-26       Impact factor: 47.728

9.  Immunization of dissociated spleen cell cultures from normal mice.

Authors:  R I Mishell; R W Dutton
Journal:  J Exp Med       Date:  1967-09-01       Impact factor: 14.307

10.  Heterogeneity of the effector cells in the cytotoxic reaction against allogeneic lymphoma cells.

Authors:  J Forman; S Britton
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

View more
  12 in total

1.  Glycosylation of the T-cell antigen-specific receptor and its potential role in lectin-mediated cytotoxicity.

Authors:  S C Hubbard; D M Kranz; G D Longmore; M V Sitkovsky; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

2.  Absence of H-2 antigens capable of reacting with cytotoxic T cells on a teratoma line expressing a T/t locus antigen.

Authors:  J Forman; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

3.  Cytotoxic T lymphocyte hybridomas that mediate specific tumor-cell lysis in vitro.

Authors:  Y Kaufmann; G Berke; Z Eshhar
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

4.  Wheat-germ agglutinin initiates monocytoid cell killing of non-antibody-coated erythrocytes.

Authors:  W Z Wei; R R Lindquist
Journal:  Immunology       Date:  1983-08       Impact factor: 7.397

5.  T lymphocyte-mediated cytolysis. III. Delineation of mechanisms whereby mitogenic and non-mitogenic lectins mediate lymphocyte-target interaction.

Authors:  G Berke; D Rosen; M Moscovitch
Journal:  Immunology       Date:  1983-08       Impact factor: 7.397

6.  On the role of the H-2 histocompatibility complex in determining the specificity of cytotoxic effector cells sensitized against syngeneic trinitrophenyl-modified targets.

Authors:  J Forman
Journal:  J Exp Med       Date:  1975-08-01       Impact factor: 14.307

7.  A clone-specific monoclonal antibody that inhibits cytolysis of a cytolytic T cell clone.

Authors:  D W Lancki; M I Lorber; M R Loken; F W Fitch
Journal:  J Exp Med       Date:  1983-03-01       Impact factor: 14.307

8.  Helper T cells are required for the polyclonal stimulation of cytotoxic T cells by concanavalin A.

Authors:  L M Pilarski; P A Bretscher; L L Baum
Journal:  J Exp Med       Date:  1977-05-01       Impact factor: 14.307

9.  Role of H-2 lymphocyte-defined and serologically-defined components in the generation of cytotoxic lymphocytes.

Authors:  B J Alter; F H Bach
Journal:  J Exp Med       Date:  1974-11-01       Impact factor: 14.307

10.  Cytotoxic T-cell activation by polyribonucleotides: DNA synthesis is not required.

Authors:  P H Bick; G Möller
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.